BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

PRL Central Laboratory Services Announces Regional Agreement With The Kansas Bioscience Organization


1/24/2007 10:45:38 AM

OVERLAND PARK, Kan., Jan. 23 /PRNewswire/ -- PRL Central Laboratory Services ("PRL") announced today that it has entered into a laboratory testing agreement with the Kansas Bioscience Organization (KansasBio) to establish a regional collaboration. Under the terms of the agreement, PRL will provide price incentives for safety and efficacy laboratory testing, toxicological testing, and employee health screening services to KansasBio and its member companies.

It typically takes close to ten years and nearly one billion dollars to test a new drug or device for commercial application. PRL plays a critical role in the process by testing the safety of the drug or device as it affects the patient during clinical trials. The data generated is a key component of a New Drug Application (NDA) which is submitted to the FDA for approval.

"We are excited to support the KansasBio organization and its initiatives to grow a regional Pharmaceutical and Biotech research community," said Christian Darabant, PRL Director of Business Development. "We are embracing the opportunity to work with KansasBio because we believe that our expertise can help accelerate promising regional research that will ultimately lead to better human and animal health for Kansas residents and the global community."

The agreement's primary beneficiaries will be the region's start-up biotech companies who will have access to PRL's clinical expertise and data management capabilities. In addition, price incentives outlined in the agreement were designed to attract and foster regional biotech growth.

About PRL Central Laboratory Services

PRL Central Laboratory Services is a privately owned, full-service diagnostic testing laboratory. As part of Physicians Reference Laboratory, LLC., PRL is uniquely positioned to satisfy customers' testing needs throughout all phases of clinical trials via an extensive and customizable test directory. At PRL, each protocol is carefully evaluated to create a precise project plan aimed at the delivery of accurate and timely laboratory data. For 30 years PRL has been renowned for incorporating new and innovative testing procedures and employing the most highly qualified professionals. By utilizing market leading technologies and providing expert service, PRL's focus is on efficiently delivering accurate diagnostic data to support the advancement of our customers' pharmaceutical development efforts, ultimately leading to the highest quality of patient care. PRL has provided services to start-up and large global pharmaceutical companies as well as local and multi-site contract research organizations.

PRL Central Laboratory Services

CONTACT: Christian T. Darabant of PRL Central Laboratory Services,+1-913-338-4070



Read at BioSpace.com

KansasBio
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES